(Q46976294)

27 December 2017

title

RBC 6-TGN and hematological parameters in patients with Crohn's disease treated by azathioprine (English)

1 reference

27 December 2017

1 reference

Pierre-Nicolas D'Halluin

1

1 reference

27 December 2017

Olivier Tribut

2

1 reference

27 December 2017

Bernard Branger

3

1 reference

27 December 2017

Christine Lebreton

4

1 reference

27 December 2017

Jean-François Bretagne

5

1 reference

27 December 2017

Danièle Bentue-Ferrer

6

1 reference

27 December 2017

Denis Heresbach

7

1 reference

27 December 2017

publication date

1 December 2005

1 reference

27 December 2017

Gastroenterologie Clinique et Biologique

published in

1 reference

27 December 2017

volume

29

1 reference

27 December 2017

issue

12

1 reference

27 December 2017

page(s)

1264-1269

1 reference

27 December 2017

Controlled trial of azathioprine in Crohn's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

A controlled double blind study of azathioprine in the management of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Assay of 6-thioguanine nucleotide, a major metabolite of azathioprine, 6-mercaptopurine and 6-thioguanine, in human red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Azathioprine metabolism in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Monitored high-dose azathioprine treatment reduces acute rejection episodes after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Should 6-thioguanine nucleotides be monitored in heart transplant recipients given azathioprine?

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

6-MP metabolite levels: a potential guide to Crohn's disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

A simple index of Crohn's-disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Observations on the incidence and cause of macrocytosis in patients on azathioprine therapy following renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Relationship between red cell mean corpuscular volume and 6-thioguanine nucleotides in patients treated with azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Thrombocytosis in chronic inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Mean platelet volume: a useful marker of inflammatory bowel disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Low-dose 6-mercaptopurine in inflammatory bowel disease is associated with minimal hematologic toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

Is neutropenia required for effective maintenance of remission during azathioprine therapy in inflammatory bowel disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2805%2982219-5

7 January 2021

10.1016/S0399-8320(05)82219-5

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017